Associations among Estimated Glomerular Filtration Rate, Proteinuria, and Adverse Cardiovascular Outcomes
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Summary: Background and objectives: Most studies of chronic kidney disease (CKD) and outcomes focus on mortality and ESRD, with limited data on other adverse outcomes. This study examined the associations among proteinuria, eGFR, and adverse cardiovascular (CV) events. Design, setting, participants, & measurements: This was a population-based longitudinal study with patients identified from province-wide laboratory data from Alberta, Canada, between 2002 and 2007. Selected for this study from a total of 1,526,437 patients were 920,985 (60.3%) patients with at least one urine dipstick measurement and 102,701 patients (6.7%) with at least one albumin-creatinine ratio (ACR) measurement. Time to hospitalization was considered for one of four indications: congestive heart failure (CHF), coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), peripheral vascular disease (PVD), and stroke/transient ischemic attacks [TIAs] (cerebrovascular accident [CVA]/TIA). Results: After a median follow-up of 35 months, in fully adjusted models and compared with patients with estimated GFR (eGFR) of 45 to 59 ml/min per 1.73 m 2 and no proteinuria, patients with heavy proteinuria by dipstick and eGFR ≥ 60 ml/min per 1.73 m 2 had higher rates of CABG/PCI and CVA/TIA. Similar results were obtained in patients with proteinuria measured by ACR. Conclusions: Risks of major CV events at a given level of eGFR increased with higher levels of proteinuria. The findings extend current data on risk of mortality and ESRD. Measurement of proteinuria is of incremental prognostic benefit at every level of eGFR. The data support use of proteinuria measurement with eGFR for definition and risk stratification in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CV death is included in the composite endpoint, alongside death from kidney failure, because of the multiple pathways and risk factors that are common to these two conditions and the resulting competing risks [31].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“It has been advocated that the use of the receiver-operating characteristic curve should be the main criterion, but others have argued in favor of other measures such as the use of Net Reclassification Improvement and Integrated Discrimination Improvement (39,40).”
Method(2010) · The Lancet · doi:10.1016/s0140-6736(10)60674-5 · Cited by 4,200 · cited 2×
“Similarly, a recent meta-analysis of 14 studies comprising 105,872 subjects found that low eGFR and increasing levels of albuminuria were independently associated with all-cause and CV mortality, but it did not report on the risk of individual CV outcomes (5).”
ResultSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Chronic Kidney Disease and Mortality Risk: A Systematic Review
Tonelli, M., Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M., McAlister, F., & Garg, A. X. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101085 · Cited by 1,658
Self-citation
Cited by
Items 101–156 of 156
Mohebi, R., Bozorgmanesh, M., Sheikholeslami, F., Azizi, F., & Hadaegh, F. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12083 · Cited by 3
Wu, X., Liu, M., Cui, L., Liu, J., Liu, L., Wu, X., Wang, Z., Cheng, A. S. K., Xie, J., & Li, X. (2020) · Psychology Health & Medicine · doi:10.1080/13548506.2020.1859560 · Cited by 3
Li, J., Wang, Y., Qi, W., Zhang, N., Tse, G., Li, G., Wu, S., & Liu, T. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14658 · Cited by 3
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD
Kazé, A. D., Patorno, E., & Paik, J. M. (2023) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000887 · Cited by 3
Experience of COVID 19 disease on 159 Ecuadorian chronic dialysis patients
Santacruz, J., Santacruz, A. C., Vásquez, A. K., Reinoso, P., Carlotta, S., & Santacruz, M. G. (2020) · Nephrology and Renal Diseases · doi:10.15761/nrd.1000174 · Cited by 3
Wadhwani, S., Mansfield, S. A., Smith, A. R., Robinson, B. M., Abdelghani, E., Al-Uzri, A. Y., Ashoor, I. F., Bartosh, S. M., Chishti, A. S., Hayek, S. S., et al. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100877 · Cited by 2
Umanath, K., Burgner, A. M., Lewis, J. B., & Dwyer, J. P. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.03.009 · Cited by 2
Umesawa, M., Hara, M., Sairenchi, T., Haruyama, Y., Nagao, M., Matsushita, M., & Kobashi, G. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021427 · Cited by 2
Wu, H., Zhou, P., Hu, L., Xu, M., & Tian, D. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2278298 · Cited by 2
Clinical Assessment and Management of Chronic Kidney Disease Across its Stages
Collins, A. K., Rosenberg, M. E., & Kimmel, P. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00005-6 · Cited by 4
Clinical Assessment and Management of Chronic Kidney Disease Across Its Stages
Collins, A. K., Rosenberg, M. E., & Kimmel, P. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00005-x · Cited by 3
Hagemann, R., Watanabe, M. T., Hueb, J. C., Martín, L. C., Silva, V. D. S., & Caramori, J. D. S. C. T. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2022-0116en · Cited by 3
Proteinuria in hospitalised internal medicine adult patients
Shimoni, Z., Froom, P., & Benbassat, J. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-141002 · Cited by 2
He, Y.-M., Chen, W., Kao, T., Wu, L., Yang, H., & Peng, T. (2022) · Nutrients · doi:10.3390/nu14194040 · Cited by 4
Discovery of novel eGFR-associated multiple independent signals using a quasi-adaptive method
Ghasemi, S., Becker, T., Grabe, H. J., & Teumer, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.997302 · Cited by 2
Nakagawa, K., Tanaka, S., Tsuruya, K., Kitazono, T., & Nakano, T. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02298-7 · Cited by 3
Massicotte‐Azarniouch, D., Kuwornu, J. P., McCallum, M. K., Bansal, N., Lam, N. N., Molnar, A. O., Pun, P. H., Zimmerman, D. L., Garg, A. X., & Sood, M. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.033 · Cited by 2
Lam, N. N., & James, M. T. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.02.002 · Cited by 2
Self-citationMaraschin, C. K., Molino, G. O. G., Alessi, J., Teló, G. H., dos Reis, M. A., & Schaan, B. D. (2025) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2024-0258 · Cited by 1
Wong, K., Pitcher, D., Barratt, J., Gale, D. P., & RaDaR Consortium (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag066 · Cited by 2
Albuminurie: Prognostischer Marker oder therapeutisches Ziel?
Chatzikyrkou, C., Haller, H. G., & Menne, J. (2012) · Der Internist · doi:10.1007/s00108-011-2891-7 · Cited by 1
Solini, A., & Castellino, P. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_8-2 · Cited by 1
Spectrum of Diabetic Kidney Disease in India - A Tertiary Care Centre Experience
Chattopadhyay, K. (2017) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000103 · Cited by 1
Secondary Hypertension and Cardiovascular Risk: An Overview
Seravalle, G., Mancia, G., & Grassi, G. M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_14 · Cited by 1
Bogner, E., Ferrero, E., Marin, J., & Bataille, S. (2021) · Bulletin de la Dialyse à Domicile · doi:10.25796/bdd.v4i2.61393 · Cited by 1
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02496-7 · Cited by 1
Albuminurie als Risikofaktor und Marker der Endorganschädigung in der Hypertonie
Chatzikyrkou, C., & Haller, H. G. (2011) · Der Nephrologe · doi:10.1007/s11560-011-0544-4
Touyz, R. M., & Grassi, G. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834a3ceb
Albuminuria and Cardiovascular Risk: Time for a New Direction?
Charytan, D. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03630411
Proteinurie: Was hat sich seit 2009 getan?
Menne, J., Chatzikyrkou, C., & Haller, H. G. (2012) · Der Nephrologe · doi:10.1007/s11560-011-0583-x
Fisher, H., Hsu, C., Vittinghoff, E., Lin, F., & Bansal, N. (2013)
Az antitestmediált rejekció diagnosztikája és kezelése gyakorlatunkban
Szabó, R. P., Amna, J. H., Kóti, N., Szilvási, A., Bidiga, L., Kardos, L., Zsom, L., Balla, J., & Nemes, B. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32267
Understanding the Instruments of Proteinuria
Pragna, S. (2021) · Journal of Kidney · doi:10.35248/2472-1220.21.7.229
Analysis of The Language Play Found in The Names of Characters in 'Asterix and Obelix'
Kusumasari, G. A. (2007)
Análisis de laboratorio e interpretación
Ramos, Z., & Cuno, L. (2022) · Instituto Universitario de Innovación Ciencia y Tecnología Inudi Perú eBooks · doi:10.35622/inudi.b.011
Solini, A., & Castellino, P. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_8
Solini, A., & Castellino, P. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_8 · Cited by 1
Solini, A., & Castellino, P. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_8-1
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.151387
Hagemann, R., Watanabe, M. T., Hueb, J. C., Martín, L. C., Silva, V. D. S., & Caramori, J. D. S. C. T. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2022-0116pt · Cited by 1
Absalan, A., Momeni, H., Salehi, A., & Karimi, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3760259/v1
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · Figshare · doi:10.6084/m9.figshare.16689620
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · Figshare · doi:10.6084/m9.figshare.16689611
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · Figshare · doi:10.6084/m9.figshare.16689617
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · Figshare · doi:10.6084/m9.figshare.16689608
Ye, H., Chen, Y., Ye, P., Zhang, Y., Liu, X., Xiao, G., Zhang, Z., Kong, Y., & Liang, G. (2021) · Figshare · doi:10.6084/m9.figshare.16689614
Renal Function Predicts Outcomes in Ischemic Stroke and Hemorrhagic Stroke
Oam, N., Mey, R., Veasna, T., Kong, K., & Suos, S. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24609234755
Kostov, K. G., Simeonova, T. N., Ignatov, B., & Eftimova, T. (2025) · Biomedicines · doi:10.3390/biomedicines13010235
Mitigating heart failure risk in patients with diabetes and chronic kidney disease
Kowalczyk, N. S., & Prochaska, M. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001208
Waheed, A., Beaulieu, M., Weber, C. L., Zalunardo, N., & Levin, A. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199592548.003.0097_update_001
Woo, H. G., & Song, T. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-29288-5
Jarrick, S., Lundberg, S., Sundström, J., Symreng, A., Warnqvist, A., & Ludvigsson, J. F. (2021) · Figshare · doi:10.6084/m9.figshare.14544745
Kofod, D. H., Carlson, N., Ballegaard, E. F., Almdal, T., Torp-Pedersen, C., Gislason, G., Svendsen, J. H., Feldt-Rasmussen, B., & Hornum, M. (2023) · Figshare · doi:10.6084/m9.figshare.23535993
Jia, X., Zhao, A., Chen, X., & Wang, S. (2026) · BMC Public Health · doi:10.1186/s12889-026-26754-1
Liu, M., Liang, Y., Zhang, Z., Bai, J., Chen, Z., & Zhou, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1938326
Metadata
- Authors
- Bello, A. K., Hemmelgarn, B., Lloyd, A., James, M. T., Manns, B. J., Klarenbach, S., & Tonelli, M.
- Affiliations
- University of Alberta (CA)
- University of Calgary (CA)
- Corresponding author
- Bello, Aminu K.
- Lloyd, Anita
- Klarenbach, Scott
- Tonelli, Marcello
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2011-06
- Volume
- 6
- Issue
- 6
- Pages
- 1418-1426
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC3109940
- OpenAlex
- W2115557520
- Cited by
- 151
- References
- 44
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 13 · 2020: 13 · 2019: 12 · 2018: 11 · 2017: 8 · 2016: 11 · 2015: 6 · 2014: 10 · 2013: 11 · 2012: 14
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Government of Canada
- University of Alberta
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, estimated glomerular filtration rate, proteinuria, albumin-creatinine ratio, cardiovascular events, congestive heart failure, coronary artery bypass grafting, percutaneous coronary intervention, peripheral vascular disease, stroke, transient ischemic attack, risk stratification, prognostic factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alberta, Coronary Artery Bypass, Cardiovascular Diseases, Ischemic Attack, Transient, Chronic Disease, Creatinine, Female, Glomerular Filtration Rate, Heart Failure, Hospitalization, Humans, Kidney, Kidney Diseases, Longitudinal Studies, Male, Middle Aged, Proteinuria, Risk Factors, Severity of Illness Index, Time Factors, Biomarkers, Angioplasty, Balloon, Coronary, Risk Assessment, Stroke, Peripheral Arterial Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.